-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dalfampridine ER in Episodic Ataxia Type 2
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalfampridine ER in Episodic Ataxia Type 2 report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalfampridine ER in Episodic Ataxia Type 2 Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-544 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-544 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-544 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: SI-544...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azetukalner in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azetukalner in Major Depressive Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azetukalner in Major Depressive Disorder Drug Details: Azetukalner (XEN-1101, 1OP-2198)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-2100 in Metastatic Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AB-2100 in Metastatic Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AB-2100 in Metastatic Renal Cell Carcinoma Drug Details: AB-2100...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMPT-514 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMPT-514 in Systemic Lupus Erythematosus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMPT-514 in Systemic Lupus Erythematosus Drug Details: IMPT-514 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMPT-514 in Lupus Nephritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMPT-514 in Lupus Nephritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMPT-514 in Lupus Nephritis Drug Details: IMPT-514 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Blarcamesine Hydrochloride in Infantile Spasm (West Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Blarcamesine Hydrochloride in Infantile Spasm (West Syndrome) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Blarcamesine Hydrochloride in Infantile Spasm (West Syndrome) Drug...
-
Product Insights
NewQuarterly Packaged Water pricing trends in the United Kingdom
Empower your strategies with our Quarterly Packaged Water pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceralasertib in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ceralasertib in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ceralasertib in Pancreatic Cancer Drug Details: Ceralasertib is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceralasertib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ceralasertib in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ceralasertib in Solid Tumor Drug Details: Ceralasertib is under development for...